 |
|
Identification of ERBB Pathway-Activated Cells in Triple-Negative Breast Cancer
Soo Young Cho
Genomics Inform. 2019;17(1):e3 Published online 2019 Mar 31 DOI: https://doi.org/10.5808/GI.2019.17.1.e3
|
|
Citations to this article as recorded by
 PH-Binding Motif in PAR4 Oncogene: From Molecular Mechanism to Drug Design
Jeetendra Kumar Nag, Hodaya Malka, Shoshana Sedley, Priyanga Appasamy, Tatyana Rudina, Tgst Levi, Amnon Hoffman, Chaim Gilon, Beatrice Uziely, Rachel Bar-Shavit
Molecular Cancer Therapeutics.2022; 21(9): 1415. CrossRef Molecular subtyping and functional validation of TTK, TPX2, UBE2C, and LRP8 in sensitivity of TNBC to paclitaxel
Ramesh Elango, Radhakrishnan Vishnubalaji, Hibah Shaath, Nehad M. Alajez
Molecular Therapy - Methods & Clinical Development.2021; 20: 601. CrossRef From Oncogenic Signaling Pathways to Single-Cell Sequencing of Immune Cells: Changing the Landscape of Cancer Immunotherapy
Afshin Derakhshani, Zeinab Rostami, Hossein Safarpour, Mahdi Abdoli Shadbad, Niloufar Sadat Nourbakhsh, Antonella Argentiero, Sina Taefehshokr, Neda Jalili Tabrizi, Omid Kooshkaki, Reza Vaezi Astamal, Pankaj Kumar Singh, Nima Taefehshokr, Nazila Alizadeh,
Molecules.2021; 26(8): 2278. CrossRef Advances of single-cell genomics and epigenomics in human disease: where are we now?
Rizqah Kamies, Celia P. Martinez-Jimenez
Mammalian Genome.2020; 31(5-6): 170. CrossRef Triple-negative breast cancer molecular subtyping and treatment progress
Li Yin, Jiang-Jie Duan, Xiu-Wu Bian, Shi-cang Yu
Breast Cancer Research.2020;[Epub] CrossRef
|